United States · FDA National Drug Code directory

Tolterodine tartrate

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
29300-307_1d40a6e0-df38-4fd8-bfea-5d19c9d071ab
Product NDC
29300-307
Form
CAPSULE, EXTENDED RELEASE
Composition / generic term
Tolterodine tartrate
Labeler
Unichem Pharmaceuticals (USA), Inc.
Marketing category
ANDA
Marketing start / end (source format)
20241001
Source listing expiry
20261231

Source-listed ingredients

  • TOLTERODINE TARTRATE — 4 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (29300-307-05) · 29300-307-05
  • 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (29300-307-13) · 29300-307-13
  • 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (29300-307-19) · 29300-307-19

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →